A high circulating FGF21 level as a prognostic marker in patients with acute myocardial infarction.

CONCLUSION: Circulating FGF21 level is elevated in the AMI patients. In AMI patients, cTnI, fibrinogen and hyperlipidemia are the inde pendent risk factors for the serum of FGF21. Higher circulating FGF21 level is associated with increased MACEs rate. This study suggests that circulating FGF21 level may be a predictive marker of the clinical outcomes in AMI patients. PMID: 30323882 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/30323882?dopt=Abstract

Source: American Journal of Translational Research - October 17, 2018 Category: Research Tags: Am J Transl Res Source Type: research